Search result
Chief Scientist Office publishes 30 university studies on COVID-19
The Chief Scientist Office has published 30 university studies funded in 2020 to contribute to global efforts to combat COVID-19. The CSO Rapid Research in COVID-19 (RARC-19) programme awarded almost £5million to 56 projects across 15 Scottish universities and research institutions, supporting research to: better understand the effects of infection develop and test new diagnostics and treatments investigate new dise...
Scottish Dementia Brain Tissue Bank to be relaunched
The Scottish Dementia Brain Tissue Bank (BTB) is being relaunched today. The BTB is a collaboration between the Alzheimer Scotland Dementia Research Centre at the University of Edinburgh (ASDRC) and the NHS Research Scotland Neuroprogressive and Dementia Research Network (NDN). Dementia affects over 50 million people worldwide and around a million people in the UK. The familiar symptoms of memory difficulties and the n...
Pharmacist members wanted for NHS Research Ethics Committee
Pharmacists are invited to join East of Scotland Research Ethics Service (EoSRES) The Research Ethics Service in Scotland is part of a UK-wide national service aimed at facilitating research, whilst simultaneously protecting the rights, safety, dignity and well-being of people participating in research in the NHS. The service is supported by the Scottish Government’s
World Cancer Day 2021
Now in its 21st year, World Cancer Day aims to inspire action to create a future without cancer In Scotland, it is estimated that two out of five people will develop cancer in their lifetime. Around half of the people diagnosed with cancer will survive for more than 10 years – a figure that has doubled in the last 40 years.[1] Research has been a v...
CSO guidance on clinical research in response to additional lockdown measures
Research, development and innovation are crucial in the response to the COVID-19 pandemic and are a core component of NHS Scotland’s role as a person-centred, evidence-based healthcare system. On January 4th, additional lockdown measures were put in place by the Scottish Government to safeguard health, save lives and protect the NHS in the context of a steep rise in Coronavir...
CSO Festive Message 2020
Euan Dick, Head of the Chief Scientist Office (CSO) reflects on 2020 as one of the most challenging and transformative years for research, paying tribute to the incredible commitment, resilience and talent of the research community across Scotland. “Last year, just three months into my post as Head of the Chief Scientist Office I used my festive message to highlight the critical imp...
Vacancy: NRS Cardiovascular Clinical Lead
The Chief Scientist Office is looking to appoint a clinical lead for NRS Cardiovascular Hours: 0.2FTE/ 2PAs per weekSalary: pro-rata within the post holder’s pay scaleLength: three years in the first instance, with the possibility to extend The remit of th...
UK wide COVID-19 study recruits the first global patient in Dundee
A phase 3 trial for the COVID-19 vaccine developed by The Janssen Pharmaceutical Companies of Johnson & Johnson has this week recruited the first global patient in Dundee. This latest study, co-funded by the UK government’s Vaccine Taskforce, and being delivered across the UK will recruit 30,000 people worldwide. It will test the safety and effectiveness of a new vaccine with two doses called ENSEMBLE 2. James Brook, Head of Clinical...
Novavax Phase 3 COVID-19 vaccine trial completes enrollment in two months
The Novavax Phase 3 COVID-19 vaccine trial has achieved its recruitment target just two months after opening in the UK - with 15,203 volunteers from across the country recruited in record time, including participants from the North East of Scotland. The Novavax study is now the largest double blind, placebo-controlled COVID-19 vaccine trial to be undertaken in the UK so far. The pivotal...
Genes could be key to new COVID-19 treatments
Potential treatments for COVID-19 have been identified after the discovery of five genes associated with the most severe form of the disease. The research led by University of Edinburgh has now been published in Nature (11 December 2020). Genetic evidence is second only to clinical trials as a way to tell which treatments will be effecti...